AKI associated with cardiac surgery

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 3, 2015, Pages 500-514

  Thiele, Robert H ^a   Isbell, James M ^a   Rosner, Mitchell H ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; BLOOD CLOTTING FACTOR 12; BRAIN NATRIURETIC PEPTIDE; CONTRAST MEDIUM; CREATININE; CYSTATIN C; DOPAMINE RECEPTOR STIMULATING AGENT; FUROSEMIDE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFUSION FLUID; INTERLEUKIN 18; INTERLEUKIN 6; KIDNEY INJURY MOLECULE 1; METHOXAMINE; NEPHROTOXIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NORADRENALIN; PENTOXIFYLLINE; PHENYLEPHRINE; PROTEINASE; TOXIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASOACTIVE AGENT;

ACUTE KIDNEY FAILURE; ALBUMINURIA; ARTIFICIAL EMBOLISM; BLOOD VESSEL INJURY; CARDIOPULMONARY BYPASS; DEATH; DISEASE ASSOCIATION; ERYTHROCYTE CONCENTRATE; HEART EJECTION FRACTION; HEART SURGERY; HEMATOCRIT; HEMODIALYSIS; HEMODYNAMICS; HEMOFILTRATION; HUMAN; HYPOXIA; IMMUNOMODULATION; INCIDENCE; INFLAMMATION; ISCHEMIC PRECONDITIONING; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; LENGTH OF STAY; META ANALYSIS (TOPIC); MORTALITY; MUSCLE CONTRACTION; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; THORAX SURGERY; TISSUE INJURY; URINE VOLUME; ACUTE KIDNEY INJURY; ADVERSE EFFECTS;

ACUTE KIDNEY INJURY; CARDIAC SURGICAL PROCEDURES; HUMANS; RISK FACTORS;

EID: 84924353980     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.07830814     Document Type: Review

References (238)

1. Kiers HD, van den Boogaard M, Schoenmakers MC, van der Hoeven JG, van Swieten HA, Heemskerk S, Pickkers P: Comparison and clinical suitability of eight prediction models for cardiac surgery-related acute kidney injury. Nephrol Dial Transplant 28: 345–351, 2013.
2. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup: Acute renal failure-definition, outcome measures, animalmodels, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8: R204–R212, 2004.
3. Lameire N, Van Biesen W, Vanholder R: Acute renal failure. Lancet 365: 417–430, 2005.
4. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A; Acute Kidney InjuryNetwork: Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care 11: R31, 2007.
5. Mariscalco G, Cottini M, Dominici C, Banach M, Piffaretti G, Borsani P, Bruno VD, Corazzari C, Gherli R, Beghi C: The effect of timing of cardiac catheterization on acute kidney injury after cardiac surgery is influenced by the type of operation. Int J Cardiol 173: 46–54, 2014.
6. Dardashti A, Ederoth P, Algotsson L, Brondén B, Bjursten H: Incidence, dynamics, and prognostic value of acute kidney injury for death after cardiac surgery. J Thorac Cardiovasc Surg 147: 800–807, 2014.
7. Mariscalco G, Nicolini F, Scannapieco A, Gherli R, Serraino F, Dominici C, Renzulli A, Gherli T, Sala A, Beghi C: Acute kidney injury after composite valve-graft replacement for ascending aorta aneurysms. Heart Vessels 28: 229–236, 2013.
8. Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettilä V: Acute renal failure after cardiac surgery: Evaluation of the RIFLE classification. Ann Thorac Surg 81: 542–546, 2006.
9. Bastin AJ, Ostermann M, Slack AJ, Diller GP, Finney SJ, Evans TW: Acute kidney injury after cardiac surgery according to Risk/ Injury/Failure/Loss/End-stage, Acute Kidney Injury Network, and Kidney Disease: Improving Global Outcomes classifications. J Crit Care 28: 389–396, 2013.
10. Robert AM, Kramer RS, Dacey LJ, Charlesworth DC, Leavitt BJ, Helm RE, Hernandez F, Sardella GL, Frumiento C, Likosky DS, Brown JR; Northern New England Cardiovascular Disease StudyGroup: Cardiac surgery-associated acute kidney injury: A comparison of two consensus criteria. Ann Thorac Surg 90: 1939–1943, 2010.
11. Machado MN, Miranda RC, Takakura IT, Palmegiani E, Santos CA, Oliveira MA, Mouco OM, Hernandes ME, Lemos MA, Maia LN: Acute kidney injury after on-pump coronary artery bypass graft surgery. Arq Bras Cardiol 93: 247–252, 2009.
12. Haase M, Bellomo R, Matalanis G, Calzavacca P, Dragun D, Haase-Fielitz A: A comparison of the RIFLE and Acute Kidney Injury Network classifications for cardiac surgery-associated acute kidney injury: A prospective cohort study. J Thorac Cardiovasc Surg 138: 1370–1376, 2009.
13. Machado MN, Nakazone MA, Maia LN: Prognostic value of acute kidney injury after cardiac surgery according to kidney disease: Improving global outcomes definition and staging (KDIGO) criteria. PLoS ONE 9: e98028, 2014.
14. Yan X, Jia S, Meng X, Dong P, Jia M, Wan J, Hou X: Acute kidney injury in adult postcardiotomy patients with extracorporeal membrane oxygenation: Evaluation of the RIFLE classification and the Acute Kidney Injury Network criteria. Eur J Cardiothorac Surg 37: 334–338, 2010.
15. Ricci Z, Di Nardo M, Iacoella C, Netto R, Picca S, Cogo P: Pediatric RIFLE for acute kidney injury diagnosis and prognosis for children undergoing cardiac surgery: A single-center prospective observational study. Pediatr Cardiol 34: 1404–1408, 2013.
16. Moran SM, Myers BD: Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int 27: 928–937, 1985.
17. Haase-Fielitz A, Bellomo R, Devarajan P, Story D, Matalanis G, Dragun D, Haase M: Novel and conventional serumbiomarkers predicting acute kidney injury in adult cardiac surgery—a prospective cohort study. Crit Care Med 37: 553–560, 2009.
18. Parikh CR, Mishra J, Thiessen-Philbrook H, Dursun B, Ma Q, Kelly C, Dent C, Devarajan P, Edelstein CL: Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 70: 199–203, 2006.
19. Koyner JL, Bennett MR, Worcester EM, Ma Q, Raman J, Jeevanandam V, Kasza KE, O’Connor MF, Konczal DJ, Trevino S, Devarajan P, Murray PT: Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int 74: 1059–1069, 2008.
20. Liangos O, Tighiouart H, Perianayagam MC, Kolyada A, Han WK, Wald R, Bonventre JV, Jaber BL: Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers 14: 423–431, 2009.
21. Koyner JL, Parikh CR: Clinical utility of biomarkers of AKI in cardiac surgery and critical illness. Clin J Am Soc Nephrol 8: 1034–1042, 2013.
22. Shlipak MG, Coca SG, Wang Z, Devarajan P, Koyner JL, Patel UD, Thiessen-Philbrook H, Garg AX, Parikh CR; TRIBE-AKI Consortium: Presurgical serum cystatin C and risk of acute kidney injury after cardiac surgery. Am J Kidney Dis 58: 366–373, 2011.
23. Zappitelli M, Coca SG, Garg AX, Krawczeski CD, Thiessen Heather P, Sint K, Li S, Parikh CR, Devarajan P; TRIBE-AKI Consortium: The association of albumin/creatinine ratio with postoperative AKI in children undergoing cardiac surgery. Clin J Am Soc Nephrol 7: 1761–1769, 2012.
24. Patel UD, Garg AX, Krumholz HM, Shlipak MG, Coca SG, Sint K, Thiessen-Philbrook H, Koyner JL, Swaminathan M, Passik CS, Parikh CR; Translational Research Investigating Biomarker Endpoints in Acute Kidney Injury (TRIBE-AKI) Consortium: Preoperative serum brain natriuretic peptide and risk of acute kidney injury after cardiac surgery. Circulation 125: 1347–1355, 2012.
25. Koyner JL, Garg AX, Coca SG, Sint K, Thiessen-Philbrook H, Patel UD, Shlipak MG, Parikh CR; TRIBE-AKI Consortium: Biomarkers predict progression of acute kidney injury after cardiac surgery. J Am Soc Nephrol 23: 905–914, 2012.
26. Coca SG, Garg AX, Thiessen-Philbrook H, Koyner JL, Patel UD, Krumholz HM, Shlipak MG, Parikh CR; TRIBE-AKI Consortium: Urinary biomarkers of AKI and mortality 3 years after cardiac surgery. J Am Soc Nephrol 25: 1063–1071, 2014.
27. Zanardo G, Michielon P, Paccagnella A, Rosi P, Caló M, Salandin V, Da Ros A, Michieletto F, Simini G: Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg 107: 1489–1495, 1994.
28. Ishani A, Nelson D, Clothier B, Schult T, Nugent S, Greer N, Slinin Y, Ensrud KE: The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch Intern Med 171: 226–233, 2011.
29. Leacche M, Rawn JD, Mihaljevic T, Lin J, Karavas AN, Paul S, Byrne JG: Outcomes in patients with normal serum creatinine and with artificial renal support for acute renal failure developing after coronary artery bypass grafting. Am J Cardiol 93: 353–356, 2004.
30. Thakar CV, Liangos O, Yared JP, Nelson DA, Hariachar S, Paganini EP: Predicting acute renal failure after cardiac surgery: Validation and re-definition of a risk-stratification algorithm. Hemodial Int 7: 143–147, 2003.
31. Thakar CV, Yared JP, Worley S, Cotman K, Paganini EP: Renal dysfunction and serious infections after open-heart surgery. Kidney Int 64: 239–246, 2003.
32. Vives M, Wijeysundera D, Marczin N, Monedero P, Rao V: Cardiac surgery-associated acute kidney injury. Interact Cardiovasc Thorac Surg 18: 637–645, 2014.
33. Sutton TA, Fisher CJ, Molitoris BA: Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 62: 1539–1549, 2002.
34. Sheridan AM, Bonventre JV: Cell biology and molecular mechanisms of injury in ischemic acute renal failure. CurrOpin Nephrol Hypertens 9: 427–434, 2000.
35. Rosner MH, Portilla D, Okusa MD: Cardiac surgery as a cause of acute kidney injury: Pathogenesis and potential therapies. J Intensive Care Med 23: 3–18, 2008.
36. Okusa MD: The inflammatory cascade in acute ischemic renal failure. Nephron 90: 133–138, 2002.
37. Moran SM, Myers BD: Pathophysiology of protracted acute renal failure in man. J Clin Invest 76: 1440–1448, 1985.
38. Molitoris BA: Transitioning to therapy in ischemic acute renal failure. J Am Soc Nephrol 14: 265–267, 2003.
39. Heinzelmann M, Mercer-Jones MA, Passmore JC: Neutrophils and renal failure. Am J Kidney Dis 34: 384–399, 1999.
40. Bellomo R, Auriemma S, Fabbri A, D’Onofrio A, Katz N, McCullough PA, Ricci Z, Shaw A, Ronco C: The pathophysiology of cardiac surgery-associated acute kidney injury (CSAAKI). Int J Artif Organs 31: 166–178, 2008.
41. Bellomo R: Acute renal failure. Semin Respir Crit Care Med 32: 639–650, 2011.
42. Shah M, Jain AK, Brunelli SM, Coca SG, Devereaux PJ, James MT, Luo J, Molnar AO, Mrkobrada M, Pannu N, Parikh CR, Paterson M, Shariff S, Wald R, Walsh M, Whitlock R, Wijeysundera DN, Garg AX: Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis. BMC Nephrol 15: 53, 2014.
43. Epstein M: Non-steroidal anti-inflammatory drugs and the continuum of renal dysfunction. J Hypertens Suppl 20: S17–S23, 2002.
44. Provenchére S, Planteféve G, Hufnagel G, Vicaut E, De Vaumas C, Lecharny JB, Depoix JP, Vrtovsnik F, Desmonts JM, Philip I: Renal dysfunction after cardiac surgery with normothermic cardiopulmonary bypass: Incidence, risk factors, and effect on clinical outcome. Anesth Analg 96: 1258–1264, 2003.
45. Del Duca D, Iqbal S, Rahme E, Goldberg P, de Varennes B: Renal failure after cardiac surgery: Timing of cardiac catheterization and other perioperative risk factors. Ann Thorac Surg 84: 1264–1271, 2007.
46. Hennessy SA, LaPar DJ, Stukenborg GJ, Stone ML, Mlynarek RA, Kern JA, Ailawadi G, Kron IL: Cardiac catheterization within 24 hours of valve surgery is significantly associated with acute renal failure. J Thorac Cardiovasc Surg 140: 1011–1017, 2010.
47. Cao L, Silvestry S, Zhao N, Diehl J, Sun J: Effects of preoperative aspirin on cardiocerebral and renal complications in nonemergent cardiac surgery patients: A sub-group and cohort study. PLoS ONE 7: e30094, 2012.
48. Kincaid EH, AshburnDA, Hoyle JR, ReichertMG, Hammon JW, Kon ND: Does the combination of aprotinin and angiotensinconverting enzyme inhibitor cause renal failure after cardiac surgery? Ann Thorac Surg 80: 1388–1393, 2005.
49. Kohan DE: Endothelins in the kidney: Physiology and pathophysiology. Am J Kidney Dis 22: 493–510, 1993.
50. Goligorsky MS, Noiri E, Tsukahara H, Budzikowski AS, Li H: A pivotal role of nitric oxide in endothelial cell dysfunction. Acta Physiol Scand 168: 33–40, 2000.
51. Caramelo C, Espinosa G, Manzarbeitia F, Cernadas MR, Pérez Tejerizo G, Tan D, Mosquera JR, Digiuni E, Montón M, Millás I, Hernando L, Casado S, López-Farré A: Role of endotheliumrelated mechanisms in the pathophysiology of renal ischemia/ reperfusion in normal rabbits. Circ Res 79: 1031–1038, 1996.
52. Donnahoo KK, Meldrum DR, Shenkar R, Chung CS, Abraham E, Harken AH: Early renal ischemia, with or without reperfusion, activates NFkappaB and increases TNF-alpha bioactivity in the kidney. J Urol 163: 1328–1332, 2000.
53. van der Linden J, Casimir-Ahn H: When do cerebral emboli appear during open heart operations? A transcranial Doppler study. Ann Thorac Surg 51: 237–241, 1991.
54. Sreeram GM, Grocott HP, White WD, Newman MF, Stafford-Smith M: Transcranial Doppler emboli count predicts rise in creatinine after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 18: 548–551, 2004.
55. Blauth CI: Macroemboli and microemboli during cardiopulmonary bypass. Ann Thorac Surg 59: 1300–1303, 1995.
56. Barbut D, Hinton RB, Szatrowski TP, Hartman GS, Bruefach M, Williams-Russo P, Charlson ME, Gold JP: Cerebral emboli detected during bypass surgery are associated with clamp removal. Stroke 25: 2398–2402, 1994.
57. Dávila-Román VG, Kouchoukos NT, Schechtman KB, Barzilai B: Atherosclerosis of the ascending aorta is a predictor of renal dysfunction after cardiac operations. J Thorac Cardiovasc Surg 117: 111–116, 1999.
58. Chronopoulos A, Rosner MH, Cruz DN, Ronco C: Acute kidney injury in the elderly:Areview. ContribNephrol 165: 315–321, 2010.
59. Chou SY, Porush JG, Faubert PF: Renal medullary circulation: Hormonal control. Kidney Int 37: 1–13, 1990.
60. Brezis M, Rosen S: Hypoxia of the renal medulla—its implications for disease. N Engl J Med 332: 647–655, 1995.
61. Morgan IS, Codispoti M, Sanger K, Mankad PS: Superiority of centrifugal pump over roller pump in paediatric cardiac surgery: Prospective randomised trial. Eur J Cardiothorac Surg 13: 526–532, 1998.
62. Wright G: Haemolysis during cardiopulmonary bypass: Update. Perfusion 16: 345–351, 2001.
63. Moat NE, Evans TE, Quinlan GJ, Gutteridge JM: Chelatable iron and copper can be released from extracorporeally circulated blood during cardiopulmonary bypass. FEBS Lett 328: 103–106, 1993.
64. Baliga R, Ueda N, Walker PD, Shah SV:Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis 29: 465–477, 1997.
65. Gutteridge JM: Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett 201: 291–295, 1986.
66. Flaherty JT, Weisfeldt ML: Reperfusion injury. Free Radic Biol Med 5: 409–419, 1988.
67. Davis CL, Kausz AT, Zager RA, Kharasch ED, Cochran RP: Acute renal failure after cardiopulmonary bypass in related to decreased serum ferritin levels. J Am Soc Nephrol 10: 2396–2402, 1999.
68. Tuttle KR, Worrall NK, Dahlstrom LR, Nandagopal R, Kausz AT, Davis CL: Predictors of ARF after cardiac surgical procedures. Am J Kidney Dis 41: 76–83, 2003.
69. Cremer J, Martin M, Redl H, Bahrami S, Abraham C, Graeter T, Haverich A, Schlag G, Borst HG: Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 61: 1714–1720, 1996.
70. Haga Y, Hatori N, Yoshizu H, Okuda E, Uriuda Y, Tanaka S: Granulocyte superoxide anion and elastase release during cardiopulmonary bypass. Artif Organs 17: 837–842, 1993.
71. Frering B, Philip I, Dehoux M, Rolland C, Langlois JM, Desmonts JM: Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 108: 636–641, 1994.
72. Paparella D, Yau TM, Young E: Cardiopulmonary bypass induced inflammation: Pathophysiology and treatment. An update. Eur J Cardiothorac Surg 21: 232–244, 2002.
73. Musial J, Niewiarowski S, Hershock D, Morinelli TA, Colman RW, Edmunds LH Jr.: Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation. J Lab Clin Med 105: 514–522, 1985.
74. Faymonville ME, Pincemail J, Duchateau J, Paulus JM, Adam A, Deby-Dupont G, Deby C, Albert A, Larbuisson R, Limet R: Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg 102: 309–317, 1991.
75. Zilla P, Fasol R, Groscurth P, Klepetko W, Reichenspurner H, Wolner E: Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation. J Thorac Cardiovasc Surg 97: 379–388, 1989.
76. Vanholder R, Argilés A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Massy ZA, Rodriguez M, Stegmayr B, Stenvinkel P, Wratten ML: Uremic toxicity: Present state of the art. Int J Artif Organs 24: 695–725, 2001.
77. McCoy RN, Hill KE, Ayon MA, Stein JH, Burk RF: Oxidant stress following renal ischemia: Changes in the glutathione redox ratio. Kidney Int 33: 812–817, 1988.
78. Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meldrum DR: Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemiareperfusion. Am J Physiol 277: R922–R929, 1999.
79. Burne-Taney MJ, Rabb H: The role of adhesion molecules and T cells in ischemic renal injury. Curr OpinNephrolHypertens 12: 85–90, 2003.
80. Andersson LG, Ekroth R, Bratteby LE, Hallhagen S, Wesslén O: Acute renal failure after coronary surgery—a study of incidence and risk factors in 2009 consecutive patients. Thorac Cardiovasc Surg 41: 237–241, 1993.
81. Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP: A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 16: 162–168, 2005.
82. Chertow GM, Lazarus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F, Daley J: Preoperative renal risk stratification. Circulation 95: 878–884, 1997.
83. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT; The Multicenter Study of Perioperative Ischemia Research Group: Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. Ann InternMed 128: 194–203, 1998.
84. Eriksen BO, Hoff KR, Solberg S: Prediction of acute renal failure after cardiac surgery: Retrospective cross-validation of a clinical algorithm. Nephrol Dial Transplant 18: 77–81, 2003.
85. Knos GB, Berry AJ, Isaacson IJ, Weitz FI: Intraoperative urinary output and postoperative blood urea nitrogen and creatinine levels in patients undergoing aortic reconstructive surgery. J Clin Anesth 1: 181–185, 1989.
86. Alpert RA, Roizen MF, Hamilton WK, Stoney RJ, Ehrenfeld WK, Poler SM, Wylie EJ: Intraoperative urinary output does not predict postoperative renal function in patients undergoing abdominal aortic revascularization. Surgery 95: 707–711, 1984.
87. Asfar P, Meziani F, Hamel JF, Grelon F, Megarbane B, Anguel N, Mira JP, Dequin PF, Gergaud S, Weiss N, Legay F, Le Tulzo Y, Conrad M, Robert R, Gonzalez F, Guitton C, Tamion F, Tonnelier JM, Guezennec P, VanDer Linden T, Vieillard-Baron A, Mariotte E, Pradel G, Lesieur O, Ricard JD, Hervé F, du Cheyron D, Guerin C, Mercat A, Teboul JL, Radermacher P; SEPSISPAM Investigators: High versus low blood-pressure target in patients with septic shock. N Engl J Med 370: 1583–1593, 2014.
88. Grängsjö G, Persson E: Influence of some vaso-active substances on regional blood flow in the dog kidney. A study on normovolaemic and hypovolaemic dogs. Acta Anaesthesiol Scand 15: 71–95, 1971.
89. Hoffbrand BI, Forsyth RP: Regional blood flow changes during norepinephrine, tyramine and methoxamine infusions in the unanesthetized rhesusmonkey. J Pharmacol Exp Ther 184: 656–661, 1973.
90. Heyndrickx GR, Boettcher DH, Vatner SF: Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am J Physiol 231: 1579–1587, 1976.
91. Argenta LC, Kirsh MM, Bove EL, Cimmino VM, Lucchesi B, Straker J, Baker R, Lee R, Sloan H: A comparison of the hemodynamic effects of inotropic agents. Ann Thorac Surg 22: 50–57, 1976.
92. Goldberg LI: Cardiovascular and renal actions of dopamine: Potential clinical applications. Pharmacol Rev 24: 1–29, 1972.
93. Brodde OE: Physiology and pharmacology of cardiovascular catecholamine receptors: Implications for treatment of chronic heart failure. Am Heart J 120: 1565–1572, 1990.
94. Koshimizu TA, Nakamura K, Egashira N, Hiroyama M, Nonoguchi H, Tanoue A: Vasopressin V1a and V1b receptors: From molecules to physiological systems. Physiol Rev 92: 1813–1864, 2012.
95. Morel A, O’Carroll AM, Brownstein MJ, Lolait SJ: Molecular cloning and expression of a rat V1a arginine vasopressin receptor. Nature 356: 523–526, 1992.
96. Sugimoto T, Saito M, Mochizuki S, Watanabe Y, Hashimoto S, Kawashima H: Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J Biol Chem 269: 27088–27092, 1994.
97. Lolait SJ, O’Carroll AM, McBride OW, Konig M, Morel A, Brownstein MJ: Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357: 336–339, 1992.
98. Birnbaumer M, Seibold A, Gilbert S, Ishido M, Barberis C, Antaramian A, Brabet P, RosenthalW: Molecular cloning of the receptor for human antidiuretic hormone. Nature 357: 333–335, 1992.
99. Landry DW, Levin HR, Gallant EM, Seo S, D’Alessandro D, Oz MC, Oliver JA: Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 25: 1279–1282, 1997.
100. Eisenman A, Armali Z, Enat R, Bankir L, Baruch Y: Low-dose vasopressin restores diuresis both in patients with hepatorenal syndrome and in anuric patients with end-stage heart failure. J Intern Med 246: 183–190, 1999.
101. Gold J, Cullinane S, Chen J, Seo S, Oz MC, Oliver JA, Landry DW: Vasopressin in the treatment ofmilrinone-induced hypotension in severe heart failure. Am J Cardiol 85: 506–508, A11, 2000.
102. Edwards RM, Trizna W, Kinter LB: Renal microvascular effects of vasopressin and vasopressin antagonists. Am J Physiol 256: F274–F278, 1989.
103. McVicar AJ: Dose-response effects of pressor doses of arginine vasopressin on renal haemodynamics in the rat. J Physiol 404: 535–546, 1988.
104. Harrison-Bernard LM, Carmines PK: Juxtamedullary microvascular responses to arginine vasopressin in rat kidney. Am J Physiol 267: F249–F256, 1994.
105. Holmes CL, Patel BM, Russell JA, Walley KR: Physiology of vasopressin relevant to management of septic shock. Chest 120: 989–1002, 2001.
106. Morelli A, Lange M, Ertmer C, Dünser M, Rehberg S, Bachetoni A, D’Alessandro M, Van Aken H, Guarracino F, Pietropaoli P, Traber DL, Westphal M: Short-term effects of phenylephrine on systemic and regional hemodynamics in patients with septic shock: A crossover pilot study. Shock 29: 446–451, 2008.
107. Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Laderchi A, Bachetoni A, D’Alessandro M, Van Aken H, Pietropaoli P, Westphal M: Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: A randomized, controlled trial. Crit Care 12: R143, 2008.
108. Patel BM, Chittock DR, Russell JA, Walley KR: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96: 576–582, 2002.
109. Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D; VASST Investigators: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358: 877–887, 2008.
110. Reinhart K, Takala J: Hydroxyethyl starches: What do we still know? Anesth Analg 112: 507–511, 2011.
111. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; SAFE Study Investigators: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350: 2247–2256, 2004.
112. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L: Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomised study. Lancet 357: 911–916, 2001.
113. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P: Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348: 1620–1622, 1996.
114. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K; German Competence Network Sepsis (SepNet): Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358: 125–139, 2008.
115. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA; CHEST Investigators; Australian and New Zealand IntensiveCare SocietyClinical Trials Group:Hydroxyethyl starch or saline for fluid resuscitation in intensive care. NEnglJMed 367: 1901–1911, 2012.
116. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J; 6S Trial Group; Scandinavian Critical Care Trials Group: Hydroxyethyl starch 130/0. 42 versus Ringer’s acetate in severe sepsis. N Engl J Med 367: 124–134, 2012.
117. Annane D, Siami S, Jaber S, Martin C, Elatrous S, Declére AD, Preiser JC, Outin H, Troché G, Charpentier C, Trouillet JL, Kimmoun A, Forceville X, Darmon M, Lesur O, Reignier J, Abroug F, Berger P, Clec’h C, Cousson J, Thibault L, Chevret S; CRISTAL Investigators: Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: The CRISTAL randomized trial. JAMA 310: 1809–1817, 2013.
118. Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, Fanizza C, Caspani L, Faenza S, Grasselli G, Iapichino G, Antonelli M, Parrini V, Fiore G, Latini R, Gattinoni L; ALBIOS Study Investigators: Albumin replacement in patients with severe sepsis or septic shock. NEngl J Med 370: 1412–1421, 2014.
119. Fischer UM, Weissenberger WK, Warters RD, Geissler HJ, Allen SJ, Mehlhorn U: Impact of cardiopulmonary bypass management on postcardiac surgery renal function. Perfusion 17: 401–406, 2002.
120. Urzua J, Troncoso S, Bugedo G, Canessa R, Muñoz H, Lema G, Valdivieso A, Irarrazaval M, Moran S, Meneses G: Renal function and cardiopulmonary bypass: Effect of perfusion pressure. J Cardiothorac Vasc Anesth 6: 299–303, 1992.
121. Abramov D, Tamariz M, Serrick CI, Sharp E, Noel D, Harwood S, Christakis GT, Goldman BS: The influence of cardiopulmonary bypass flow characteristics on the clinical outcome of 1820 coronary bypass patients. Can J Cardiol 19: 237–243, 2003.
122. Rudy LW Jr., Heymann MA, Edmunds LH Jr.: Distribution of systemic blood flow during cardiopulmonary bypass. J Appl Physiol 34: 194–200, 1973.
123. Slater JM, Orszulak TA, Cook DJ: Distribution and hierarchy of regional blood flow during hypothermic cardiopulmonary bypass. Ann Thorac Surg 72: 542–547, 2001.
124. Gold JP, Charlson ME, Williams-Russo P, Szatrowski TP, Peterson JC, Pirraglia PA, Hartman GS, Yao FS, Hollenberg JP, Barbut D, Hayes JG, Thomas SJ, Purcell MH, Mattis S, Gorkin L: Improvement of outcomes after coronary artery bypass. A randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg 110: 1302–1311, 1995.
125. Palmer BF: Renal dysfunction complicating the treatment of hypertension. N Engl J Med 347: 1256–1261, 2002.
126. Kelleher SP, Robinette JB, Conger JD: Sympathetic nervous system in the loss of autoregulation in acute renal failure. Am J Physiol 246: F379–F386, 1984.
127. Loef BG, Epema AH, Navis G, Ebels T, van Oeveren W, Henning RH: Off-pump coronary revascularization attenuates transient renal damage compared with on-pump coronary revascularization. Chest 121: 1190–1194, 2002.
128. Ascione R, Lloyd CT, Underwood MJ, Gomes WJ, Angelini GD: On-pump versus off-pump coronary revascularization: Evaluation of renal function. Ann Thorac Surg 68: 493–498, 1999.
129. Stallwood MI, Grayson AD, Mills K, Scawn ND: Acute renal failure in coronary artery bypass surgery: Independent effect of cardiopulmonary bypass. Ann Thorac Surg 77: 968–972, 2004.
130. Chawla LS, Zhao Y, Lough FC, Schroeder E, Seneff MG, Brennan JM: Off-pump versus on-pump coronary artery bypass grafting outcomes stratified by preoperative renal function. J Am Soc Nephrol 23: 1389–1397, 2012.
131. Garg AX, Devereaux PJ, Yusuf S, Cuerden MS, Parikh CR, Coca SG, Walsh M, Novick R, Cook RJ, Jain AR, Pan X, Noiseux N, Vik K, Stolf NA, Ritchie A, Favaloro RR, Parvathaneni S, Whitlock RP, Ou Y, Lawrence M, Lamy A; CORONARY Investigators: Kidney function after off-pump or on-pump coronary artery bypass graft surgery: A randomized clinical trial. JAMA 311: 2191–2198, 2014.
132. Schwann NM, Horrow JC, Strong MD 3rd, Chamchad D, Guerraty A, Wechsler AS: Does off-pump coronary artery bypass reduce the incidence of clinically evident renal dysfunction after multivessel myocardial revascularization? Anesth Analg 99: 959–964, 2004.
133. Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, Straka Z, Piegas LS, Akar AR, Jain AR, Noiseux N, Padmanabhan C, Bahamondes JC, Novick RJ, Vaijyanath P, Reddy SK, Tao L, Olavegogeascoechea PA, Airan B, Sulling TA, Whitlock RP, Ou Y, Pogue J, Chrolavicius S, Yusuf S;CORONARY Investigators: Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. N Engl J Med 368: 1179–1188, 2013.
134. Fransen E, Maessen J, Dentener M, Senden N, Geskes G, Buurman W: Systemic inflammation present in patients undergoing CABG without extracorporeal circulation. Chest 113: 1290–1295, 1998.
135. Dybdahl B, Wahba A, Haaverstad R, Kirkeby-Garstad I, Kierulf P, Espevik T, Sundan A: On-pump versus off-pump coronary artery bypass grafting: More heat-shock protein 70 is released after on-pump surgery. Eur J Cardiothorac Surg 25: 985–992, 2004.
136. Swaminathan M, Phillips-Bute BG, Conlon PJ, Smith PK, Newman MF, Stafford-Smith M: The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg 76: 784–791, 2003.
137. Karkouti K, Beattie WS, Wijeysundera DN, Rao V, Chan C, Dattilo KM, Djaiani G, Ivanov J, Karski J, David TE: Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg 129: 391–400, 2005.
138. Surgenor SD, DeFoe GR, Fillinger MP, Likosky DS, Groom RC, Clark C, Helm RE, Kramer RS, Leavitt BJ, Klemperer JD, Krumholz CF, Westbrook BM, Galatis DJ, Frumiento C, Ross CS, Olmstead EM, O’Connor GT: Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure. Circulation 114[Suppl]: I43–I48, 2006.
139. Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, Fukushima J, Kalil Filho R, Sierra DB, Lopes NH, Mauad T, Roquim AC, Sundin MR, Leaõ WC, Almeida JP, Pomerantzeff PM, Dallan LO, Jatene FB, Stolf NA, Auler JO Jr.: Transfusion requirements after cardiac surgery: The TRACS randomized controlled trial. JAMA 304: 1559–1567, 2010.
140. Bennett-Guerrero E, Zhao Y, O’Brien SM, Ferguson TB Jr., Peterson ED, Gammie JS, Song HK: Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA 304: 1568–1575, 2010.
141. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care TrialsGroup. NEngl J Med 340: 409–417, 1999.
142. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, Nemo G, Dragert K, Beaupre L, Hildebrand K, Macaulay W, Lewis C, Cook DR, Dobbin G, Zakriya KJ, Apple FS, Horney RA, Magaziner J; FOCUS Investigators: Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 365: 2453–2462, 2011.
143. Surgenor SD, Kramer RS, Olmstead EM, Ross CS, Sellke FW, Likosky DS, Marrin CA, Helm RE Jr., Leavitt BJ, Morton JR, Charlesworth DC, Clough RA, Hernandez F, Frumiento C, Benak A, DioData C, O’Connor GT; Northern New England Cardiovascular Disease Study Group: The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg 108: 1741–1746, 2009.
144. Karkouti K: Transfusion and risk of acute kidney injury in cardiac surgery. Br J Anaesth 109[Suppl 1]: i29–i38, 2012.
145. Tchetche D, Van der Boon RM, Dumonteil N, Chieffo A, Van Mieghem NM, Farah B, Buchanan GL, Saady R, Marcheix B, Serruys PW, Colombo A, Carrie D, De Jaegere PP, Fajadet J: Adverse impact of bleeding and transfusion on the outcome post-transcatheter aortic valve implantation: Insights from the Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC Plus) initiative. Am Heart J 164: 402–409, 2012.
146. Nuis RJ, Rodés-Cabau J, Sinning JM, van Garsse L, Kefer J, Bosmans J, Dager AE, van Mieghem N, Urena M, Nickenig G, Werner N, Maessen J, Astarci P, Perez S, Benitez LM, Dumont E, van Domburg RT, de Jaegere PP: Blood transfusion and the risk of acute kidney injury after transcatheter aortic valve implantation. Circ Cardiovasc Interv 5: 680–688, 2012.
147. Khan UA, Coca SG, Hong K, Koyner JL, Garg AX, Passik CS, Swaminathan M, Garwood S, Patel UD, Hashim S, Quantz MA, Parikh CR: Blood transfusions are associated with urinary biomarkers of kidney injury in cardiac surgery. J Thorac Cardiovasc Surg 148: 726–732, 2014.
148. Leaf DE, Rajapurkar M, Lele SS, Mukhopadhyay B, Waikar SS: Plasma catalytic iron, AKI, and death among critically ill patients [published online ahead of print September 4, 2014]. Clin J Am Soc Nephrol doi: CJN. 02840314.
149. Pattakos G, Koch CG, Brizzio ME, Batizy LH, Sabik JF 3rd, Blackstone EH, Lauer MS: Outcome of patients who refuse transfusion after cardiac surgery: A natural experimentwith severe blood conservation. Arch Intern Med 172: 1154–1160, 2012.
150. Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, Blackstone EH: Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 358: 1229–1239, 2008.
151. Aubron C, Nichol A, Cooper DJ, Bellomo R: Age of red blood cells and transfusion in critically ill patients. Ann Intensive Care 3: 2, 2013.
152. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in critically ill patients. N Engl J Med 345: 1359–1367, 2001.
153. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, VanWijngaerden E, Bobbaers H, Bouillon R: Intensive insulin therapy in the medical ICU. N Engl J Med 354: 449–461, 2006.
154. Wiener RS, Wiener DC, Larson RJ: Benefits and risks of tight glucose control in critically ill adults: A meta-analysis. JAMA 300: 933–944, 2008.
155. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O’Brien PC, Johnson MG, Williams AR, Cutshall SM, Mundy LM, Rizza RA, McMahon MM: Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: A randomized trial. Ann Intern Med 146: 233–243, 2007.
156. Bhamidipati CM, LaPar DJ, Stukenborg GJ, Morrison CC, Kern JA, Kron IL, Ailawadi G: Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 141: 543–551, 2011.
157. Ahlers O, Nachtigall I, Lenze J, Goldmann A, Schulte E, Höhne C, Fritz G, Keh D: Intraoperative thoracic epidural anaesthesia attenuates stress-induced immunosuppression in patients undergoing major abdominal surgery. Br J Anaesth 101: 781–787, 2008.
158. Caputo M, Alwair H, Rogers CA, Ginty M, Monk C, Tomkins S, Mokhtari A, Angelini GD: Myocardial, inflammatory, and stress responses in off-pump coronary artery bypass graft surgery with thoracic epidural anesthesia. Ann Thorac Surg 87: 1119–1126, 2009.
159. Scott NB, Turfrey DJ, Ray DA, Nzewi O, Sutcliffe NP, Lal AB, Norrie J, Nagels WJ, Ramayya GP: A prospective randomized study of the potential benefits of thoracic epidural anesthesia and analgesia in patients undergoing coronary artery bypass grafting. Anesth Analg 93: 528–535, 2001.
160. Stenger M, Fabrin A, Schmidt H, Greisen J, Erik Mortensen P, Jakobsen CJ: High thoracic epidural analgesia as an adjunct to general anesthesia is associated with better outcome in lowto-moderate risk cardiac surgery patients. J Cardiothorac Vasc Anesth 27: 1301–1309, 2013.
161. Svircevic V, Passier MM, Nierich AP, van Dijk D, Kalkman CJ, van der Heijden GJ: Epidural analgesia for cardiac surgery. Cochrane Database Syst Rev 6: CD006715, 2013.
162. Scrascia G, Guida P, Rotunno C, de Luca Tupputi, Schinosa L, Paparella D: Anti-inflammatory strategies to reduce acute kidney injury in cardiac surgery patients: A meta-analysis of randomized controlled trials. Artif Organs 38: 101–112, 2014.
163. Whitlock R, Teoh K, Vincent J, Devereaux PJ, Lamy A, Paparella D, Zuo Y, Sessler DI, Shah P, Villar JC, Karthikeyan G, Urrutia G, Alvezum A, Zhang X, Abbasi SH, Zheng H, Quantz M, Yared JP, Yu H, Noiseux N, Yusuf S: Rationale and design of the steroids in cardiac surgery trial. Am Heart J 167: 660–665, 2014.
164. Marik PE, Baram M, Vahid B: Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 134: 172–178, 2008.
165. Kalantari K, Chang JN, Ronco C, Rosner MH: Assessment of intravascular volume status and volume responsiveness in critically ill patients. Kidney Int 83: 1017–1028, 2013.
166. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, HillegeHL: Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53: 582–588, 2009.
167. Miller TE, Roche AM, Gan TJ: Poor adoption of hemodynamic optimization during major surgery: Are we practicing substandard care? Anesth Analg 112: 1274–1276, 2011.
168. Gurgel ST, do Nascimento P Jr.: Maintaining tissue perfusion in high-risk surgical patients: A systematic review of randomized clinical trials. Anesth Analg 112: 1384–1391, 2011.
169. Hamilton MA, Cecconi M, Rhodes A: A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. AnesthAnalg 112: 1392–1402, 2011.
170. Zhuang CL, Ye XZ, Zhang XD, Chen BC, Yu Z: Enhanced recovery after surgery programs versus traditional care for colorectal surgery: A meta-analysis of randomized controlled trials. Dis Colon Rectum 56: 667–678, 2013.
171. Donati A, Loggi S, Preiser JC, Orsetti G, Münch C, Gabbanelli V, Pelaia P, Pietropaoli P: Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk surgical patients. Chest 132: 1817–1824, 2007.
172. Pölönen P, Ruokonen E, Hippeläinen M, Pöyhönen M, Takala J: A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg 90: 1052–1059, 2000.
173. Goepfert MS, Richter HP, Zu Eulenburg C, Gruetzmacher J, Rafflenbeul E, Roeher K, von Sandersleben A, Diedrichs S, Reichenspurner H, Goetz AE, Reuter DA: Individually optimized hemodynamic therapy reduces complications and length of stay in the intensive care unit: A prospective, randomized controlled trial. Anesthesiology 119: 824–836, 2013.
174. Sugahara S, Suzuki H: Early start on continuous hemodialysis therapy improves survival rate in patients with acute renal failure following coronary bypass surgery. Hemodial Int 8: 320–325, 2004.
175. Durmaz I, Yagdi T, Calkavur T, Mahmudov R, Apaydin AZ, Posacioglu H, Atay Y, Engin C: Prophylactic dialysis in patients with renal dysfunction undergoing on-pump coronary artery bypass surgery. Ann Thorac Surg 75: 859–864, 2003.
176. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J: Effects of early high-volume continuous venovenoushemofiltration onsurvival andrecovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial. Crit Care Med 30: 2205–2211, 2002.
177. Foroughi M, Argani H, Hassntash SA, Hekmat M, Majidi M, Beheshti M, Mehdizadeh B, Yekani B: Lack of renal protection of ultrafiltration during cardiac surgery: A randomized clinical trial. J Cardiovasc Surg (Torino) 55: 407–413, 2014.
178. Karvellas CJ, Farhat MR, Sajjad I, Mogensen SS, Leung AA, Wald R, Bagshaw SM: A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: A systematic review and meta-analysis. Crit Care 15: R72, 2011.
179. Reichenspurner H, Navia JA, Berry G, Robbins RC, Barbut D, Gold JP, Reichart B: Particulate emboli capture by an intra-aortic filter device during cardiac surgery. J Thorac Cardiovasc Surg 119: 233–241, 2000.
180. Gerriets T, Schwarz N, Sammer G, Baehr J, Stolz E, Kaps M, Kloevekorn WP, Bachmann G, Schönburg M: Protecting the brain from gaseous and solid micro-emboli during coronary artery bypass grafting: A randomized controlled trial. EurHeart J 31: 360–368, 2010.
181. Gho BC, Schoemaker RG, van den Doel MA, Duncker DJ, Verdouw PD: Myocardial protection by brief ischemia in noncardiac tissue. Circulation 94: 2193–2200, 1996.
182. Gassanov N, Nia AM, Caglayan E, Er F: Remote ischemic preconditioning and renoprotection: From myth to a novel therapeutic option? J Am Soc Nephrol 25: 216–224, 2014.
183. Yang Y, Lang XB, Zhang P, Lv R, Wang YF, Chen JH: Remote ischemic preconditioning for prevention of acute kidney injury: A meta-analysis of randomized controlled trials. Am J Kidney Dis 64: 574–583, 2014.
184. Tögel FE, Westenfelder C: Kidney protection and regeneration following acute injury: Progress through stem cell therapy. Am J Kidney Dis 60: 1012–1022, 2012.
185. Rosner MH, Okusa MD: Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 1: 19–32, 2006.
186. Thompson JW, Jacobs RF: Adverse effects of newer cephalosporins. An update. Drug Saf 9: 132–142, 1993.
187. Cappelletty D, Jablonski A, Jung R: Risk factors for acute kidney injury in adult patients receiving vancomycin. Clin Drug Investig 34: 189–193, 2014.
188. Pagkalis S, Mantadakis E, Mavros MN, Ammari C, Falagas ME: Pharmacological considerations for the proper clinical use of aminoglycosides. Drugs 71: 2277–2294, 2011.
189. Musu M, Finco G, Antonucci R, Polati E, Sanna D, Evangelista M, Ribuffo D, Schweiger V, Fanos V: Acute nephrotoxicity of NSAID from the foetus to the adult. Eur Rev Med Pharmacol Sci 15: 1461–1472, 2011.
190. D’Agati V: Does aspirin cause acute or chronic renal failure in experimental animals and in humans? Am J Kidney Dis 28 [Suppl 1]: S24–S29, 1996.
191. McDonald JS, McDonald RJ, Comin J, Williamson EE, Katzberg RW, Murad MH, Kallmes DF: Frequency of acute kidney injury following intravenous contrast medium administration: A systematic reviewandmeta-analysis. Radiology 267: 119–128, 2013.
192. Flechner SM, Kobashigawa J, Klintmalm G: Calcineurin inhibitorsparing regimens in solid organ transplantation: Focus on improving renal function and nephrotoxicity. Clin Transplant 22: 1–15, 2008.
193. Yacoub R, Patel N, Lohr JW, Rajagopalan S, Nader N, Arora P: Acute kidney injury and death associated with renin angiotensin system blockade in cardiothoracic surgery: A meta-analysis of observational studies. Am J Kidney Dis 62: 1077–1086, 2013.
194. Coca SG, Garg AX, Swaminathan M, Garwood S, Hong K, Thiessen-Philbrook H, Passik C, Koyner JL, Parikh CR; TRIBEAKI Consortium: Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery. Nephrol Dial Transplant 28: 2787–2799, 2013.
195. Woo EB, Tang AT, el-Gamel A, Keevil B, Greenhalgh D, Patrick M, Jones MT, Hooper TL: Dopamine therapy for patients at risk of renal dysfunction following cardiac surgery: Science or fiction? Eur J Cardiothorac Surg 22: 106–111, 2002.
196. Tang AT, El-Gamel A, Keevil B, Yonan N, Deiraniya AK: The effect of ‘renal-dose’ dopamine on renal tubular function following cardiac surgery: Assessed by measuring retinol binding protein (RBP). Eur J Cardiothorac Surg 15: 717–721, 1999.
197. Friedrich JO, Adhikari N, Herridge MS, Beyene J: Meta-analysis: Low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 142: 510–524, 2005.
198. Denton MD, Chertow GM, Brady HR: “Renal-dose” dopamine for the treatment of acute renal failure: Scientific rationale, experimental studies and clinical trials. Kidney Int 50: 4-14, 1996.
199. Ranucci M, Soro G, Barzaghi N, Locatelli A, Giordano G, Vavassori A, Manzato A, Melchiorri C, Bove T, Juliano G, Uslenghi MF: Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients. Ann Thorac Surg 78: 1332–1337, 2004.
200. Ranucci M, De Benedetti D, Bianchini C, Castelvecchio S, Ballotta A, Frigiola A, Menicanti L: Effects of fenoldopam infusion in complex cardiac surgical operations: A prospective, randomized, double-blind, placebo-controlled study. Minerva Anestesiol 76: 249–259, 2010.
201. Garwood S, Swamidoss CP, Davis EA, Samson L, Hines RL: A case series of low-dose fenoldopam in seventy cardiac surgical patients at increased risk of renal dysfunction. J Cardiothorac Vasc Anesth 17: 17–21, 2003.
202. Caimmi PP, Pagani L, Micalizzi E, Fiume C, Guani S, Bernardi M, Parodi F, Cordero G, Fregonara M, Kapetanakis E, Panella M, Degasperis C: Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 17: 491–494, 2003.
203. Bove T, Landoni G, Calabro MG, Aletti G, Marino G, Cerchierini E, Crescenzi G, Zangrillo A: Renoprotective action of fenoldopamin high-risk patients undergoing cardiac surgery: A prospective, double-blind, randomized clinical trial. Circulation 111: 32303235, 2005.
204. Zangrillo A, Biondi-Zoccai GG, Frati E, Covello RD, Cabrini L, Guarracino F, Ruggeri L, Bove T, Bignami E, Landoni G: Fenoldopam and acute renal failure in cardiac surgery: A metaanalysis of randomized placebo-controlled trials. J Cardiothorac Vasc Anesth 26: 407–413, 2012.
205. Jarnberg PO: Renal protection strategies in the perioperative period. Best Pract Res Clin Anaesthesiol 18: 645–660, 2004.
206. Lombardi R, Ferreiro A, Servetto C: Renal function after cardiac surgery: Adverse effect of furosemide. Ren Fail 25: 775–786, 2003.
207. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M: Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 11: 97–104, 2000.
208. Waikar SS, Bonventre JV: Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 20: 672–679, 2009.
209. Mahesh B, Yim B, Robson D, Pillai R, Ratnatunga C, Pigott D: Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial. Eur J Cardiothorac Surg 33: 370–376, 2008.
210. Rigden SP, Dillon MJ, Kind PR, de Leval M, Stark J, Barratt TM: The beneficial effect of mannitol on postoperative renal function in children undergoing cardiopulmonary bypass surgery. Clin Nephrol 21: 148–151, 1984.
211. Ip-Yam PC, Murphy S, Baines M, Fox MA, Desmond MJ, Innes PA: Renal function and proteinuria after cardiopulmonary bypass: The effects of temperature and mannitol. Anesth Analg 78: 842–847, 1994.
212. Fisher AR, Jones P, Barlow P, Kennington S, Saville S, Farrimond J, Yacoub M: The influence ofmannitol on renal function during and after open-heart surgery. Perfusion 13: 181–186, 1998.
213. Carcoana OV, Mathew JP, Davis E, Byrne DW, Hayslett JP, Hines RL, Garwood S: Mannitol and dopamine in patients undergoing cardiopulmonary bypass: A randomized clinical trial. Anesth Analg 97: 1222–1229, 2003.
214. Swärd K, Valsson F, Odencrants P, Samuelsson O, Ricksten SE: Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial. Crit Care Med 32: 1310–1315, 2004.
215. Mentzer RM Jr., Oz MC, Sladen RN, Graeve AH, Hebeler RF Jr., Luber JM Jr., Smedira NG; NAPA Investigators: Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: The NAPA Trial. J Am Coll Cardiol 49: 716–726, 2007.
216. Sezai A, Hata M, Niino T, Yoshitake I, Unosawa S, Wakui S, Fujita K, Takayama T, Kasamaki Y, Hirayama A, Minami K: Continuous low-dose infusion of human atrial natriuretic peptide in patients with left ventricular dysfunction undergoing coronary artery bypass grafting: The NU-HIT (Nihon University working group study of low-dose Human ANP Infusion Therapy during cardiac surgery) for left ventricular dysfunction. J Am Coll Cardiol 55: 1844–1851, 2010.
217. Sezai A, Hata M, Niino T, Yoshitake I, Unosawa S, Wakui S, Kimura H, Shiono M, Takayama T, Hirayama A: Results of lowdose human atrial natriuretic peptide infusion in nondialysis patients with chronic kidney disease undergoing coronary artery bypass grafting: The NU-HIT (Nihon University working group study of low-dose HANP Infusion Therapy during cardiac surgery) trial for CKD. J Am Coll Cardiol 58: 897–903, 2011.
218. Myles PS, Hunt JO, Holdgaard HO, McRae R, Buckland MR, Moloney J, Hall J, Bujor MA, Esmore DS, Davis BB, Morgan DJ: Clonidine and cardiac surgery: Haemodynamic and metabolic effects, myocardial ischaemia and recovery. Anaesth Intensive Care 27: 137–147, 1999.
219. Kulka PJ, Tryba M, Zenz M: Preoperative alpha2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: Results of a randomized, controlled trial. Crit Care Med 24: 947–952, 1996.
220. Devereaux PJ, Sessler DI, Leslie K, Kurz A, Mrkobrada M, Alonso-Coello P, Villar JC, Sigamani A, Biccard BM, Meyhoff CS, Parlow JL, Guyatt G, Robinson A, Garg AX, Rodseth RN, Botto F, Lurati Buse G, Xavier D, Chan MT, Tiboni M, Cook D, Kumar PA, Forget P, Malaga G, Fleischmann E, Amir M, Eikelboom J, Mizera R, Torres D, Wang CY, Vanhelder T, Paniagua P, Berwanger O, Srinathan S, Graham M, Pasin L, Le Manach Y, Gao P, Pogue J, Whitlock R, Lamy A, Kearon C, Chow C, Pettit S, Chrolavicius S, Yusuf S; POISE-2 Investigators: Clonidine in patients undergoing noncardiac surgery. N Engl J Med 370: 1504–1513, 2014.
221. Leino K, Hynynen M, Jalonen J, Salmenperä M, Scheinin H, Aantaa R; Dexmedetomidine in Cardiac Surgery Study Group: Renal effects of dexmedetomidine during coronary artery bypass surgery: A randomized placebo-controlled study. BMC Anesthesiol 11: 9, 2011.
222. Tossios P, Bloch W, Huebner A, Raji MR, Dodos F, Klass O, Suedkamp M, Kasper SM, Hellmich M, Mehlhorn U: Nacetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: Results of a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 126: 1513–1520, 2003.
223. Sucu N, Cinel I, Unlu A, Aytacoglu B, Tamer L, Kocak Z, Karaca K, Gul A, Dikmengil M, Atik U, Oral U: N-acetylcysteine for preventing pump-induced oxidoinflammatory response during cardiopulmonary bypass. Surg Today 34: 237–242, 2004.
224. Golshahi J, Nasri H, Gharipour M: Contrast-induced nephropathy; A literature review. J Nephropathol 3: 51–56, 2014.
225. Wang G, Bainbridge D, Martin J, Cheng D: N-acetylcysteine in cardiac surgery: Do the benefits outweigh the risks? A metaanalytic reappraisal. J Cardiothorac Vasc Anesth 25: 268–275, 2011.
226. Morariu AM, Loef BG, Aarts LP, Rietman GW, Rakhorst G, van Oeveren W, Epema AH: Dexamethasone: Benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting: A study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest 128: 2677–2687, 2005.
227. Loef BG, Henning RH, Epema AH, Rietman GW, van Oeveren W, Navis GJ, Ebels T: Effect of dexamethasone on perioperative renal function impairment during cardiac surgery with cardiopulmonary bypass. Br J Anaesth 93: 793–798, 2004.
228. Layton JB, Kshirsagar AV, Simpson RJ Jr., Pate V, Jonsson Funk M, Stürmer T, Brookhart MA: Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. Am J Cardiol 111: 823–828, 2013.
229. Huffmyer JL, Mauermann WJ, Thiele RH, Ma JZ, Nemergut EC: Preoperative statin administration is associated with lower mortality and decreased need for postoperative hemodialysis in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 23: 468–473, 2009.
230. Beattie WS, Wijeysundera DN: Statins and the “healthy user bias” in cardiac surgery. Anesth Analg 111: 261–263, 2010.
231. Argalious M, Xu M, Sun Z, Smedira N, Koch CG: Preoperative statin therapy is not associated with a reduced incidence of postoperative acute kidney injury after cardiac surgery. Anesth Analg 111: 324–330, 2010.
232. Truwit JD, Bernard GR, Steingrub J, Matthay MA, Liu KD, Albertson TE, Brower RG, Shanholtz C, Rock P, Douglas IS, deBoisblanc BP, Hough CL, Hite RD, Thompson BT; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network: Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med 370: 2191–2200, 2014.
233. Krämer BK, Preuner J, Ebenburger A, Kaiser M, Bergner U, Eilles C, Kammerl MC, Riegger GA, Birnbaum DE: Lack of renoprotective effect of theophylline during aortocoronary bypass surgery. Nephrol Dial Transplant 17: 910–915, 2002.
234. Cağli K, Ulasx MM, Ozisxik K, Kale A, Bakuy V, Emir M, Balci M, Topbasx M, Sener E, Tasxdemir O: The intraoperative effect of pentoxifylline on the inflammatory process and leukocytes in cardiac surgery patients undergoing cardiopulmonary bypass. Perfusion 20: 45–51, 2005.
235. Fansa I, Gol M, Nisanoglu V, Yavas S, Iscan Z, Tasdemir O:Does diltiazem inhibit the inflammatory response in cardiopulmonary bypass? Med Sci Monit 9: PI30–PI36, 2003.
236. Chanda J, Canver CC: Reversal of preexisting vasospasm in coronary artery conduits. Ann Thorac Surg 72: 476–480, 2001.
237. Bergman AS, Odar-Cederlö f I, Westman L, Bjellerup P, Höglund P, Ohqvist G: Diltiazem infusion for renal protection in cardiac surgical patients with preexisting renal dysfunction. J Cardiothorac Vasc Anesth 16: 294–299, 2002.
238. Haase M, Haase-Fielitz A, Plass M, Kuppe H, Hetzer R, Hannon C, Murray PT, Bailey MJ, Bellomo R, Bagshaw SM: Prophylactic perioperative sodium bicarbonate to prevent acute kidney injury following open heart surgery: A multicenter doubleblinded randomized controlled trial. PLoS Med 10: e1001426, 2013.